Sort
51,570 grants matching “autoimmune disease”
Molecular Control of TCR Signaling and Function
$435,000Dario Aa Vignali · St. Jude Children'S Research Hospital · R56 · FY2010 · AI
Leukocyte Adhesion Receptors Mac-1 and P150,95
$435,000Timothy A Springer · Boston Children'S Hospital · R01 · FY2017 · AI
Characterization of new Ca2+ channels that underpin immunological decision making
$435,000Jean-Pierre M Kinet · Beth Israel Deaconess Medical Center · R01 · FY2014 · AI
Investigation of Beta2-glycoprotein I Complexes in Antiphospholipid Syndrome
$435,000Natalia Beglova · Beth Israel Deaconess Medical Center · R01 · FY2011 · HL
Cellular Immunity to JC Virus in AIDS-Associated Progressive Multifocal Leukoence
$435,000Igor J Koralnik · Beth Israel Deaconess Medical Center · R56 · FY2010 · NS
Characterization of new Ca2+ channels that underpin immunological decision making
$435,000Jean-Pierre M Kinet · Beth Israel Deaconess Medical Center · R01 · FY2012 · AI
BCAP/PI3K regulation of innate immunity to Listeria monocytogenes
$435,000Jessica A Hamerman · Benaroya Research Inst At Virginia Mason · R01 · FY2019 · AI
Modulation of erythrocyte function by complement
$435,000Ionita Calin Ghiran · Beth Israel Deaconess Medical Center · R01 · FY2011 · HL
Leukocyte Adhesion Receptors Mac-1 and P150,95
$435,000Timothy A Springer · Boston Children'S Hospital · R01 · FY2016 · AI
Mechanisms of R loop-mediated genome instability in Wiskott-Aldrich syndrome
$434,941Yatin M Vyas · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2022 · AI
Inter-junctional signaling in epithelial junctional complex
$434,925Sergey M. Troyanovsky · Northwestern University At Chicago · R56 · FY2015 · AR
Molecular Control of TCR Signaling and Function
$434,896Dario Aa Vignali · St. Jude Children'S Research Hospital · R01 · FY2011 · AI
Biogenesis of voltage-gated K+ channels
$434,869Carol J Deutsch · University Of Pennsylvania · R01 · FY2021 · GM
Project 1
$434,862Mark A Atkinson · University Of Florida · P01 · FY2025 · AI
Role of Tim-3:Bat-3 pathway in inducing tolerogenic DCs and peripheral tolerance
$434,860Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2022 · AI
Role of Tim-3:Bat-3 pathway in inducing tolerogenic DCs and peripheral tolerance
$434,860Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2020 · AI
Development of Drugs that Modify CNS Innate Immunity for the Treatment of Multiple Sclerosis
$434,860Francisco J. Quintana · Brigham And Women'S Hospital · R33 · FY2025 · NS
Regulators of Ca+ NFAT signaling a global RNAi screen
$434,860Immune Disease Institute, Inc. · R01 · FY2005 · GM
Role of Tim-3:Bat-3 pathway in inducing tolerogenic DCs and peripheral tolerance
$434,860Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2021 · AI
Development of Drugs that Modify CNS Innate Immunity for the Treatment of Multiple Sclerosis
$434,860Francisco J. Quintana · Brigham And Women'S Hospital · R61 · FY2023 · NS
Development of drugs that modify CNS innate immunity for the treatment of Multiple Sclerosis
$434,860Francisco J. Quintana · Brigham And Women'S Hospital · R61 · FY2022 · NS
Role of Tim-3:Bat-3 pathway in inducing tolerogenic DCs and peripheral tolerance
$434,860Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2024 · AI
Role of Tim-3:Bat-3 pathway in inducing tolerogenic DCs and peripheral tolerance
$434,860Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2023 · AI
Engineering synthetic ligands with potent allosteric inhibition of tumornecrosis factor receptors
$434,853Benjamin Hackel · University Of Minnesota · R01 · FY2021 · EB
STRUCTURAL BASIS OF MURINE DIABETES
$434,850Scripps Research Institute · R01 · FY2002 · DK